Global Biopharma Contract Manufacturing

As Boehringer Ingelheim BioXcellence™, we're offering biopharmaceutical contract development and manufacturing services to the biopharmaceutical industry. Our expertise ranges from mammalian cell cultures to microbial fermentation.

We're raising the bar with our cGMP-certified biopharma multi-product facility at the Vienna site.

Today’s plant, tomorrow’s products

As the demand for innovative medicines grows worldwide, Boehringer Ingelheim is stepping up to meet the challenge. Our new GMP-certified, multi-product cell culture facility in Vienna expands global biopharmaceutical capacity by 30%, housing 48 bioreactors with a total volume of 185,000 liters. Designed for flexibility, automation, and rapid changeovers, this state-of-the-art site ensures reliable delivery of monoclonal antibodies, enzymes, and other recombinant proteins.

It’s more than a plant, it’s a commitment to patients and the future of healthcare.

Our large-scale cell culture facility

Boehringer Ingelheim BioXcellence™

As one of the global leaders in biopharmaceutical contract manufacturing with more than 40 years of biotechnology experience and a worldwide network of biopharma manufacturing facilities, our track record speaks for itself. Find out more about partnering with us.

References